Skip to content

Investigation of pulmonary oxygenation and biological factors associated with Phenotypes and outcomes in acute hypoxic respiratory failure patients receiving High-Flow Nasal Cannula:a multicenter, prospective, observational, cohort study

Investigation of pulmonary oxygenation and biological factors associated with Phenotypes and outcomes in acute hypoxic respiratory failure patients receiving High-Flow Nasal Cannula:a multicenter, prospective, observational, cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300067433
Enrollment
Unknown
Registered
2023-01-07
Start date
2022-12-31
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute hypoxic respiratory failure

Interventions

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Acute onset within 1 week of known clinical impairment (i.e. risk factors) or new/aggravated respiratory symptoms within 1 week (unknown clinical impairment); 2. Continuous use of HFNC(Flow=30L/min) for more than 12 hours; 3. Acute hypoxic respiratory failure (PaO2/FiO2=300 mmHg, PaCO2= 45mmHg) 4. Sign the informed consent form

Exclusion criteria

Exclusion criteria: Main exclusion criteria: 1. Acute exacerbations of severe asthma or chronic respiratory failure (including chronic obstructive pulmonary disease, interstitial lung disease, or other underlying chronic respiratory diseases); 2. Cardiogenic pulmonary edema 3. Enrolled patients requiring emergency endotracheal intubation (evaluated by clinicians, including life-threatening hypoxemia, cardiac or respiratory arrest, etc.); 4. Patients need selective intubation 5. Patients with HFNC after extubation; 6. Patients who refuse endotracheal intubation Secondary exclusion criteria 1. Patients who refused endotracheal intubation during study period;

Design outcomes

Primary

MeasureTime frame
Intubation rate within 7 days after inclusion;

Secondary

MeasureTime frame
Proportion of patients meeting the diagnostic criteria for ARDS before and after endotracheal intubation;28-day mortality;Incidence of organ dysfunction;Length of ICU stay;

Countries

China

Contacts

Public ContactChen Hui

The First Affiliated Hospital of Soochow University, Soochow University

15905162429@163.com18006138640

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026